CLINICAL_TRIALS
trial_result
· 2019-06-27
Clinical Trial Update: Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease [Phase 2]
Summary
Phase 2 clinical trial update for Abrilumab (AMG 181) in adults with moderate to severe Crohn's disease; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-06-27